Geode Capital Management LLC Boosts Position in Petmed Express Inc (PETS)

Geode Capital Management LLC increased its stake in Petmed Express Inc (NASDAQ:PETS) by 5.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 241,812 shares of the company’s stock after purchasing an additional 11,956 shares during the quarter. Geode Capital Management LLC owned approximately 1.17% of Petmed Express worth $5,624,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Great West Life Assurance Co. Can raised its holdings in shares of Petmed Express by 2.0% in the 4th quarter. Great West Life Assurance Co. Can now owns 26,411 shares of the company’s stock worth $566,000 after purchasing an additional 508 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Petmed Express by 688.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 58,130 shares of the company’s stock worth $1,919,000 after purchasing an additional 50,756 shares during the period. Canada Pension Plan Investment Board raised its holdings in shares of Petmed Express by 46.3% in the 4th quarter. Canada Pension Plan Investment Board now owns 135,200 shares of the company’s stock worth $3,144,000 after purchasing an additional 42,800 shares during the period. Morgan Stanley raised its holdings in shares of Petmed Express by 110.1% in the 3rd quarter. Morgan Stanley now owns 312,416 shares of the company’s stock worth $10,313,000 after purchasing an additional 163,691 shares during the period. Finally, Oregon Public Employees Retirement Fund bought a new stake in shares of Petmed Express in the 4th quarter worth approximately $183,000. 95.04% of the stock is currently owned by institutional investors.

A number of research firms recently commented on PETS. BidaskClub raised shares of Petmed Express from a “sell” rating to a “hold” rating in a report on Wednesday, January 16th. ValuEngine cut shares of Petmed Express from a “hold” rating to a “sell” rating in a report on Monday, February 4th. Finally, Craig Hallum lowered their price target on shares of Petmed Express from $25.00 to $18.00 and set a “sell” rating on the stock in a report on Wednesday, January 23rd. Three investment analysts have rated the stock with a sell rating and two have given a hold rating to the company’s stock. The stock has a consensus rating of “Sell” and an average target price of $28.00.

Petmed Express stock opened at $22.31 on Friday. Petmed Express Inc has a 1-year low of $20.25 and a 1-year high of $46.83. The company has a market capitalization of $461.24 million, a P/E ratio of 11.10 and a beta of 0.51.

Petmed Express (NASDAQ:PETS) last released its quarterly earnings data on Tuesday, January 22nd. The company reported $0.38 earnings per share for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.10). Petmed Express had a net margin of 14.43% and a return on equity of 32.89%. The business had revenue of $60.10 million during the quarter, compared to analysts’ expectations of $64.22 million. During the same quarter in the prior year, the firm posted $0.44 earnings per share. The firm’s quarterly revenue was up .0% on a year-over-year basis.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://www.baseballdailydigest.com/news/2019/04/21/geode-capital-management-llc-boosts-position-in-petmed-express-inc-pets.html.

About Petmed Express

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Recommended Story: What type of investment options does a Roth IRA provide?

Institutional Ownership by Quarter for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.